-+ 0.00%
-+ 0.00%
-+ 0.00%

CUE BIOPHARMA INC - CUE-401 WELL TOLERATED WITH NO ADVERSE EVENTS IN STUDIES

Reuters·02/17/2026 13:00:12

Please log in to view news